{"symbol": "JNJ", "publishedDate": "2021-01-19 07:01:00", "publisher": "The Motley Fool", "title": "2 Top Dividend Kings to Buy and Hold Forever", "image": "https://images.financialmodelingprep.com/news/2-top-dividend-kings-to-buy-and-hold-forever-20210119.jpg", "site": "fool.com", "text": "You can just sit back and watch the cash roll in with these two top stocks.", "url": "https://www.fool.com/investing/2021/01/19/2-top-dividend-kings-to-buy-and-hold-forever/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-19T07:01:00-05:00", "date_et": "2021-01-19"}
{"symbol": "JNJ", "publishedDate": "2021-01-19 09:00:00", "publisher": "Forbes", "title": "Johnson & Johnson's Covid-19 Vaccine Updates: Efficacy Figures, Production Delays", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-covid19-vaccine-updates-efficacy-figures-production-delays-20210119.jpg", "site": "forbes.com", "text": "Johnson & Johnson is developing one of the most closely watched Covid-19 vaccines, considering that it is a single-dose shot that should be relatively easy to distribute. Here's a quick rundown on the recent developments for the vaccine.", "url": "https://www.forbes.com/sites/greatspeculations/2021/01/19/johnson--johnsons-covid-19-vaccine-updates-efficacy-figures-production-delays/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-19T09:00:00-05:00", "date_et": "2021-01-19"}
{"symbol": "JNJ", "publishedDate": "2021-01-19 09:05:12", "publisher": "Seeking Alpha", "title": "Invest Like A Billionaire With High Yield: THW", "image": "https://images.financialmodelingprep.com/news/invest-like-a-billionaire-with-high-yield-thw-20210119.jpg", "site": "seekingalpha.com", "text": "Invest Like A Billionaire With High Yield: THW", "url": "https://seekingalpha.com/article/4399114-invest-like-billionaire-high-yield-thw", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-19T09:05:12-05:00", "date_et": "2021-01-19"}
{"symbol": "JNJ", "publishedDate": "2021-01-19 09:07:23", "publisher": "Forbes", "title": "Allison Transmission, Korn Ferry, & Johnson & Johnson: Poised To Outperform", "image": "https://images.financialmodelingprep.com/news/allison-transmission-korn-ferry-johnson-johnson-poised-to-outperform-20210119.jpg", "site": "forbes.com", "text": "Starting 2021 by looking at the Long Ideas that performed poorly in 2020 that I remain bullish on.", "url": "https://www.forbes.com/sites/greatspeculations/2021/01/19/allison-transmission-korn-ferry--johnson--johnson-poised-to-outperform/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-19T09:07:23-05:00", "date_et": "2021-01-19"}
{"symbol": "JNJ", "publishedDate": "2021-01-19 13:17:36", "publisher": "Investopedia", "title": "Healthcare Stocks Appear Set to Move Higher", "image": "https://images.financialmodelingprep.com/news/healthcare-stocks-appear-set-to-move-higher-20210119.jpg", "site": "investopedia.com", "text": "Nearby levels of support and recent closes beyond key resistance are creating lucrative risk/reward setups in the healthcare sector.", "url": "https://www.investopedia.com/healthcare-stocks-appear-set-to-move-higher-5095993", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-19T13:17:36-05:00", "date_et": "2021-01-19"}
{"symbol": "JNJ", "publishedDate": "2021-01-19 15:48:27", "publisher": "InvestorPlace", "title": "The 7 Best Stocks To Buy In The Dow Jones Today", "image": "https://images.financialmodelingprep.com/news/the-7-best-stocks-to-buy-in-the-dow-20210119.jpg", "site": "investorplace.com", "text": "The Dow Jones Industrial Index is one of the cornerstone indexes of the U.S. markets. But it's more consumer-driven now.", "url": "https://investorplace.com/2021/01/the-7-best-stocks-to-buy-in-the-dow-jones-today/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-19T15:48:27-05:00", "date_et": "2021-01-19"}
{"symbol": "JNJ", "publishedDate": "2021-01-20 03:41:50", "publisher": "Seeking Alpha", "title": "Dividend Income Summary: Bert's December 2020 Summary - New Record", "image": "https://images.financialmodelingprep.com/news/dividend-income-summary-berts-december-2020-summary-new-record-20210120.jpg", "site": "seekingalpha.com", "text": "In December, we received $4,699.20 in dividend income. That is a 23.4% increase compared to last year. We received $3,500 from our retirement accounts this month alone. In total, our dividend income increased nearly $10 from dividend increases.", "url": "https://seekingalpha.com/article/4399836-dividend-income-summary-berts-december-2020-summary-new-record", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-20T03:41:50-05:00", "date_et": "2021-01-20"}
{"symbol": "JNJ", "publishedDate": "2021-01-20 09:27:52", "publisher": "Seeking Alpha", "title": "In This Overheated Market, It's Not If But When. Here's How To Prepare", "image": "https://images.financialmodelingprep.com/news/in-this-overheated-market-its-not-if-but-when-20210120.jpg", "site": "seekingalpha.com", "text": "In This Overheated Market, It's Not If But When. Here's How To Prepare", "url": "https://seekingalpha.com/article/4399873-in-this-overheated-market-not-when-how-to-prepare", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-20T09:27:52-05:00", "date_et": "2021-01-20"}
{"symbol": "JNJ", "publishedDate": "2021-01-20 11:03:11", "publisher": "InvestorPlace", "title": "9 Beginner Stocks for First-Time Investors", "image": "https://images.financialmodelingprep.com/news/9-beginner-stocks-for-firsttime-investors-20210120.jpg", "site": "investorplace.com", "text": "If you have a long-term outlook for your portfolio, these beginner stocks to buy should make you very happy down the line. The post 9 Beginner Stocks for First-Time Investors appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/9-beginner-stocks-for-first-time-investors-to-buy/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-20T11:03:11-05:00", "date_et": "2021-01-20"}
{"symbol": "JNJ", "publishedDate": "2021-01-20 11:52:55", "publisher": "InvestorPlace", "title": "Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today", "image": "https://images.financialmodelingprep.com/news/covid19-vaccine-roundup-5-pharma-stocks-making-the-biggest-20210120.jpg", "site": "investorplace.com", "text": "Covid-19 pharma stocks like NVAX stock and BNTX stock are making headlines as Joe Biden promises to vaccinate 100 million Americans. The post Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/covid-19-vaccine-5-pharma-stocks-headlines-today-nvax-stock-bntx-stock/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-20T11:52:55-05:00", "date_et": "2021-01-20"}
{"symbol": "JNJ", "publishedDate": "2021-01-20 18:48:20", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-stock-sinks-as-market-gains-what-20210120.jpg", "site": "zacks.com", "text": "In the latest trading session, Johnson & Johnson (JNJ) closed at $162.38, marking a -0.25% move from the previous day.", "url": "https://www.zacks.com/stock/news/1249437/johnson-johnson-jnj-stock-sinks-as-market-gains-what-you-should-know", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-20T18:48:20-05:00", "date_et": "2021-01-20"}
{"symbol": "JNJ", "publishedDate": "2021-01-21 00:33:00", "publisher": "The Motley Fool", "title": "These 3 Stocks Just Hit All-Time Highs -- And They Still Look Unstoppable", "image": "https://images.financialmodelingprep.com/news/these-3-stocks-just-hit-alltime-highs-and-they-20210121.jpg", "site": "fool.com", "text": "Don't let an expensive share price stop you from buying the best.", "url": "https://www.fool.com/investing/2021/01/21/these-3-stocks-just-hit-all-time-highs-and-they-st/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-21T00:33:00-05:00", "date_et": "2021-01-21"}
{"symbol": "JNJ", "publishedDate": "2021-01-21 04:30:00", "publisher": "Seeking Alpha", "title": "Medical Device Aristocrats For A High Class Dividend Portfolio", "image": "https://images.financialmodelingprep.com/news/medical-device-aristocrats-for-a-high-class-dividend-portfolio-20210121.jpg", "site": "seekingalpha.com", "text": "Healthcare aristocrats benefit from significant medical device contributions. By and large these healthcare aristocrats share favorable quant metrics on Seeking Alpha, albeit with significant variations among the five.", "url": "https://seekingalpha.com/article/4400093-medical-device-aristocrats-for-high-class-dividend-portfolio", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-21T04:30:00-05:00", "date_et": "2021-01-21"}
{"symbol": "JNJ", "publishedDate": "2021-01-21 06:09:00", "publisher": "The Motley Fool", "title": "3 COVID Stocks to Buy if You're Not a Big Risk-Taker", "image": "https://images.financialmodelingprep.com/news/3-covid-stocks-to-buy-if-youre-not-a-20210121.jpg", "site": "fool.com", "text": "These stocks won't keep you up at night.", "url": "https://www.fool.com/investing/2021/01/21/3-covid-stocks-to-buy-if-youre-not-a-big-risk-take/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-21T06:09:00-05:00", "date_et": "2021-01-21"}
{"symbol": "JNJ", "publishedDate": "2021-01-21 07:07:00", "publisher": "The Motley Fool", "title": "Is Johnson & Johnson a Buy?", "image": "https://images.financialmodelingprep.com/news/is-johnson-johnson-a-buy-20210121.jpeg", "site": "fool.com", "text": "This innovative drugmaker is expecting multiple growth catalysts in 2021.", "url": "https://www.fool.com/investing/2021/01/21/is-johnson-johnson-a-buy/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-21T07:07:00-05:00", "date_et": "2021-01-21"}
{"symbol": "JNJ", "publishedDate": "2021-01-21 10:22:30", "publisher": "The Dog of Wall Street", "title": "Are Biotech Stocks a Good Idea Right Now?", "image": "https://images.financialmodelingprep.com/news/are-biotech-stocks-a-good-idea-right-now-20210121.jpg", "site": "thedogofwallstreet.com", "text": "Take a look at a few trending biotech stocks and decide if this is something you want to invest in.", "url": "https://thedogofwallstreet.com/axsm/are-biotech-stocks-a-good-idea-right-now", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-21T10:22:30-05:00", "date_et": "2021-01-21"}
{"symbol": "JNJ", "publishedDate": "2021-01-21 11:31:00", "publisher": "Seeking Alpha", "title": "Allison Transmission, Korn Ferry And Johnson & Johnson: 3 Long Ideas Poised To Outperform", "image": "https://images.financialmodelingprep.com/news/allison-transmission-korn-ferry-and-johnson-johnson-3-long-20210121.jpg", "site": "seekingalpha.com", "text": "Starting 2021 by looking at the Long Ideas that performed poorly in 2020. Despite their underperformance, we remain bullish on these stocks, and they all remain open long ideas.", "url": "https://seekingalpha.com/article/4400184-allison-transmission-korn-ferry-and-johnson-johnson-3-long-ideas-poised-to-outperform", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-21T11:31:00-05:00", "date_et": "2021-01-21"}
{"symbol": "JNJ", "publishedDate": "2021-01-21 21:01:56", "publisher": "CNBC", "title": "Johnson & Johnson plans to have 100 million vaccines for Americans by spring, board member says", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-plans-to-have-100-million-vaccines-for-20210121.jpeg", "site": "cnbc.com", "text": "A J&J board member said “if the clinical trial works out,” the company could significantly increase the nation's Covid vaccine supply availability.", "url": "https://www.cnbc.com/2021/01/21/jj-plans-to-have-100-million-vaccines-for-americans-by-spring-board-member-says.html", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-21T21:01:56-05:00", "date_et": "2021-01-21"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 04:51:08", "publisher": "Seeking Alpha", "title": "2020 Portfolio Activity Summary And 2021 Target", "image": "https://images.financialmodelingprep.com/news/2020-portfolio-activity-summary-and-2021-target-20210122.jpg", "site": "seekingalpha.com", "text": "2020, for our investments, was a good year. We kept the cash from the Emera sale for emergency funds during the first lockdown when we weren't working.", "url": "https://seekingalpha.com/article/4400341-2020-portfolio-activity-summary-and-2021-target", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T04:51:08-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 06:16:00", "publisher": "The Motley Fool", "title": "3 Cheap Dividend Aristocrats to Buy Right Now", "image": "https://images.financialmodelingprep.com/news/3-cheap-dividend-aristocrats-to-buy-right-now-20210122.jpg", "site": "fool.com", "text": "The lowest yield on this list is 2.5% and well above what the average S&P 500 stock pays today.", "url": "https://www.fool.com/investing/2021/01/22/3-cheap-dividend-aristocrats-to-buy-right-now/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T06:16:00-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 06:43:45", "publisher": "Benzinga", "title": "Johnson & Johnson Could Have 100 Million COVID-19 Vaccines By April, Board Member McClellan Says", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-could-have-100-million-covid19-vaccines-by-20210122.jpg", "site": "benzinga.com", "text": "Bloomberg reports that Johnson & Johnson (NYSE: JNJ) is on track to analyze data from its late-stage single-dose COVID-19 vaccine trial. Dr. Anthony Fauci said in his remarks at the White House that JNJ has enough data to begin analysis in a week or two.", "url": "https://www.benzinga.com/general/biotech/21/01/19270827/johnson-johnson-could-have-100-million-covid-19-vaccines-by-april-board-member-mcclellan-says", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T06:43:45-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 08:24:33", "publisher": "New York Post", "title": "One-shot COVID-19 vaccine may give Johnson & Johnson an edge", "image": "https://images.financialmodelingprep.com/news/oneshot-covid19-vaccine-may-give-johnson-johnson-an-edge-20210122.jpg", "site": "nypost.com", "text": "Less may be more when it comes to rolling out a coronavirus vaccine. Johnson & Johnson's one-dose vaccine could have an edge over Pfizer and Moderna's shots– even though it's still several weeks away from approval in the US, Wall Street analysts told The Post.", "url": "https://nypost.com/2021/01/22/one-shot-covid-vaccine-could-give-johnson-johnson-an-edge/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T08:24:33-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 09:07:28", "publisher": "New York Post", "title": "Johnson & Johnson eyes 100M COVID-19 vaccines for US by April", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-eyes-100m-covid19-vaccines-for-us-by-20210122.jpg", "site": "nypost.com", "text": "Johnson & Johnson hopes to have enough COVID-19 vaccines for 100 million Americans by April as the feds ramp up nationwide inoculation efforts, a company official says.", "url": "https://nypost.com/2021/01/22/johnson-johnson-eyes-100-million-covid-vaccines-by-april/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T09:07:28-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 09:26:00", "publisher": "Barron's", "title": "Johnson & Johnson Aims for 100 Million Vaccine Doses by Spring. The Stock Market Is Counting on It.", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-aims-for-100-million-vaccine-doses-by-spring-20210122.jpg", "site": "barrons.com", "text": "More data on the Johnson & Johnson vaccine, expected in the coming days, will have ripple effects across the market.", "url": "https://www.barrons.com/articles/johnson-johnson-aims-for-100-million-vaccine-doses-by-spring-the-stock-market-is-counting-on-it-51611325577", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T09:26:00-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 09:47:27", "publisher": "Zacks Investment Research", "title": "J&J (JNJ) to Get the Ball Rolling for Pharma Q4 Earnings", "image": "https://images.financialmodelingprep.com/news/jj-jnj-to-get-the-ball-rolling-for-pharma-20210122.jpeg", "site": "zacks.com", "text": "J&J's (JNJ) Pharma segment is expected to have performed above market while continued procedure stabilization is expected to have benefited the Medical Devices segment in the fourth quarter.", "url": "https://www.zacks.com/stock/news/1250356/jj-jnj-to-get-the-ball-rolling-for-pharma-q4-earnings", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T09:47:27-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 10:17:27", "publisher": "Benzinga", "title": "J&J Snack Foods's Earnings: A Preview", "image": "https://images.financialmodelingprep.com/news/jj-snack-foodss-earnings-a-preview-20210122.jpg", "site": "benzinga.com", "text": "J&J Snack Foods (NASDAQ:JJSF) announces its next round of earnings this Monday, January 25. Here is Benzinga's everything-that-matters guide for this Monday's Q1 earnings announcement.", "url": "https://www.benzinga.com/news/earnings/21/01/19274371/j-j-snack-foodss-earnings-a-preview", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T10:17:27-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 11:17:06", "publisher": "Zacks Investment Research", "title": "Q4 Earnings Come to Regional Banks: ALLY, HBAN & More", "image": "https://images.financialmodelingprep.com/news/q4-earnings-come-to-regional-banks-ally-hban-more-20210122.jpg", "site": "zacks.com", "text": "Most of the Big Banks have already posted for Q4; this morning we see a large share of Regional Banks reporting quarterly earnings.", "url": "https://www.zacks.com/stock/news/1250524/q4-earnings-come-to-regional-banks-ally-hban-more", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T11:17:06-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 12:02:06", "publisher": "Zacks Investment Research", "title": "Regional Banks Post Mixed Earnings Results", "image": "https://images.financialmodelingprep.com/news/regional-banks-post-mixed-earnings-results-20210122.jpg", "site": "zacks.com", "text": "Regional Banks Post Mixed Earnings Results.", "url": "https://www.zacks.com/stock/news/1250555/regional-banks-post-mixed-earnings-results", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T12:02:06-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 13:54:37", "publisher": "Seeking Alpha", "title": "Sana Biotechnology Seeks $150 Million U.S. IPO", "image": "https://images.financialmodelingprep.com/news/sana-biotechnology-seeks-150-million-us-ipo-20210122.jpg", "site": "seekingalpha.com", "text": "Sana Biotechnology Seeks $150 Million U.S. IPO", "url": "https://seekingalpha.com/article/4400435-sana-biotechnology-seeks-150-million-u-s-ipo", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T13:54:37-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 15:48:05", "publisher": "Zacks Investment Research", "title": "Q4 and 2021 Earnings Estimates Keep Going Up", "image": "https://images.financialmodelingprep.com/news/q4-and-2021-earnings-estimates-keep-going-up-20210122.jpg", "site": "zacks.com", "text": "Q4 and 2021 Earnings Estimates Keep Going Up", "url": "https://www.zacks.com/commentary/1250712/q4-and-2021-earnings-estimates-keep-going-up", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T15:48:05-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-22 16:08:00", "publisher": "The Motley Fool", "title": "Top Coronavirus Vaccine Makers Will Earn Up to $23 Billion in Revenue This Year, Says New Analysis", "image": "https://images.financialmodelingprep.com/news/top-coronavirus-vaccine-makers-will-earn-up-to-23-20210122.jpg", "site": "fool.com", "text": "Moderna and Pfizer/BioNTech should rake in similar levels of revenue for their vaccines.", "url": "https://www.fool.com/investing/2021/01/22/top-coronavirus-vaccine-makers-will-earn-up-to-23/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-22T16:08:00-05:00", "date_et": "2021-01-22"}
{"symbol": "JNJ", "publishedDate": "2021-01-23 18:13:00", "publisher": "Market Watch", "title": "The New York Post: Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks", "image": "https://images.financialmodelingprep.com/news/the-new-york-post-fauci-says-johnson-johnson-covid19-20210123.jpg", "site": "marketwatch.com", "text": "The first single-dose COVID-19 vaccine could get emergency approval in just two weeks, Dr. Anthony Fauci said late Friday.", "url": "https://www.marketwatch.com/story/fauci-says-johnson-johnson-covid-19-vaccine-may-get-approval-in-two-weeks-11611443596", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-23T18:13:00-05:00", "date_et": "2021-01-23"}
{"symbol": "JNJ", "publishedDate": "2021-01-24 05:04:50", "publisher": "Seeking Alpha", "title": "Week 4 MDA Breakout Stocks - January 2021: Short-Term Picks To Give You An Edge", "image": "https://images.financialmodelingprep.com/news/week-4-mda-breakout-stocks-january-2021-shortterm-picks-20210124.jpg", "site": "seekingalpha.com", "text": "Two new breakout stocks for Week 4 of 2021 with better than 10% short-term upside potential. This past week 3 out of 4 stocks gained over 10% in a short trading week but gave back most of their gains closing for an avg loss of -4.1%. 2021 MDA portfolio returns are on record pace up +36.3% in the first three weeks with 10 out of 12 picks gaining more than 10% in less than a week.", "url": "https://seekingalpha.com/article/4400583-week-4-mda-breakout-stocks-january-2021-short-term-picks-to-give-you-edge", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-24T05:04:50-05:00", "date_et": "2021-01-24"}
{"symbol": "JNJ", "publishedDate": "2021-01-24 07:10:00", "publisher": "The Motley Fool", "title": "Where to Invest $1 Million Right Now", "image": "https://images.financialmodelingprep.com/news/where-to-invest-1-million-right-now-20210124.jpg", "site": "fool.com", "text": "With a nest egg this sizable, you'll need to find more than one place to put your money so it keeps growing.", "url": "https://www.fool.com/investing/2021/01/24/where-to-invest-1-million-right-now/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-24T07:10:00-05:00", "date_et": "2021-01-24"}
{"symbol": "JNJ", "publishedDate": "2021-01-24 09:15:00", "publisher": "The Motley Fool", "title": "3 Bargain Stocks You Can Buy Right Now", "image": "https://images.financialmodelingprep.com/news/3-bargain-stocks-you-can-buy-right-now-20210124.jpg", "site": "fool.com", "text": "These dividend stocks all look like great long-term buys.", "url": "https://www.fool.com/investing/2021/01/24/3-bargain-stocks-you-can-buy-right-now/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-24T09:15:00-05:00", "date_et": "2021-01-24"}
{"symbol": "JNJ", "publishedDate": "2021-01-24 16:39:12", "publisher": "Seeking Alpha", "title": "Week In Review: Suzhou's Adagene To Stage $125 Million IPO On NASDAQ", "image": "https://images.financialmodelingprep.com/news/week-in-review-suzhous-adagene-to-stage-125-million-20210124.jpg", "site": "seekingalpha.com", "text": "Week In Review: Suzhou's Adagene To Stage $125 Million IPO On NASDAQ", "url": "https://seekingalpha.com/article/4400664-week-in-review-suzhous-adagene-to-stage-125-million-ipo-on-nasdaq", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-24T16:39:12-05:00", "date_et": "2021-01-24"}
{"symbol": "JNJ", "publishedDate": "2021-01-25 07:00:00", "publisher": "Forbes", "title": "Should You Buy Johnson & Johnson Stock At $160?", "image": "https://images.financialmodelingprep.com/news/should-you-buy-johnson-johnson-stock-at-160-20210125.jpg", "site": "forbes.com", "text": "Despite a 45% rise since the March 23 lows of last year, at the current price of around $161 per share we believe that pharmaceuticals bellwether, Johnson & Johnson, looks attractive and it can see more upside from the current levels. JNJ stock has rallied from $111 to $161, underperforming.", "url": "https://www.forbes.com/sites/greatspeculations/2021/01/25/should-you-buy-johnson--johnson-stock-at-160/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-25T07:00:00-05:00", "date_et": "2021-01-25"}
{"symbol": "JNJ", "publishedDate": "2021-01-25 10:43:35", "publisher": "InvestorPlace", "title": "5 Biden-Friendly Warren Buffett Stocks to Load Up On", "image": "https://images.financialmodelingprep.com/news/5-bidenfriendly-warren-buffett-stocks-to-load-up-on-20210125.jpeg", "site": "investorplace.com", "text": "With President Joe Biden now in the White House, these five Warren Buffett stocks have the advantage of attractive, stable returns. The post 5 Biden-Friendly Warren Buffett Stocks to Load Up On appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/5-biden-friendly-warren-buffett-stocks-to-load-up-on-ko-gm-jnj-tmus-mco/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-25T10:43:35-05:00", "date_et": "2021-01-25"}
{"symbol": "JNJ", "publishedDate": "2021-01-25 11:13:11", "publisher": "Seeking Alpha", "title": "Don't Buy, Hold, And Hope For The Best", "image": "https://images.financialmodelingprep.com/news/dont-buy-hold-and-hope-for-the-best-20210125.jpg", "site": "seekingalpha.com", "text": "Don't Buy, Hold, And Hope For The Best", "url": "https://seekingalpha.com/article/4400788-dont-buy-hold-and-hope-for-best", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-25T11:13:11-05:00", "date_et": "2021-01-25"}
{"symbol": "JNJ", "publishedDate": "2021-01-25 12:37:38", "publisher": "Market Watch", "title": "J&J may share findings from Phase 3 vaccine trial this week", "image": "https://images.financialmodelingprep.com/news/jj-may-share-findings-from-phase-3-vaccine-trial-20210125.jpeg", "site": "marketwatch.com", "text": "Shares of Johnson & Johnson were up 0.9% in trading on Monday, as the company nears the anticipated disclosure of interim results from a late-stage clinical trial evaluating its single-dose COVID-19 vaccine candidate. J&J said in mid-December it expects to share findings from the Phase 3 trial by the end of January, which would it the third company testing coronavirus vaccines in the U.S. to announce results from a closely watched Phase 3 trial.", "url": "https://www.marketwatch.com/story/jj-may-share-findings-from-phase-3-vaccine-trial-this-week-2021-01-25", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-25T12:37:38-05:00", "date_et": "2021-01-25"}
{"symbol": "JNJ", "publishedDate": "2021-01-25 15:17:00", "publisher": "Barron's", "title": "The Market Is Looking to Johnson & Johnson for Hope After a Grim Morning", "image": "https://images.financialmodelingprep.com/news/the-market-is-looking-to-johnson-johnson-for-hope-20210125.jpg", "site": "barrons.com", "text": "After Moderna and Merck's news, the path for a swift vaccine rollout looks a bit rockier than it did last week.", "url": "https://www.barrons.com/articles/it-was-a-grim-morning-in-the-covid-19-fight-the-market-is-looking-to-johnson-johnson-for-hope-51611605861", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-25T15:17:00-05:00", "date_et": "2021-01-25"}
{"symbol": "JNJ", "publishedDate": "2021-01-25 16:19:02", "publisher": "Benzinga", "title": "J&J Snack Foods: Q1 Earnings Insights", "image": "https://images.financialmodelingprep.com/news/jj-snack-foods-q1-earnings-insights-20210125.jpg", "site": "benzinga.com", "text": "Shares of J&J Snack Foods (NASDAQ:JJSF) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 90.32% over the past year to $0.09, which missed the estimate of $0.20.", "url": "https://www.benzinga.com/news/earnings/21/01/19308870/j-j-snack-foods-q1-earnings-insights", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-25T16:19:02-05:00", "date_et": "2021-01-25"}
{"symbol": "JNJ", "publishedDate": "2021-01-25 16:36:51", "publisher": "Investor's Business Daily", "title": "Covid Vaccines: Here's What J&J Has To Do To Undercut Pfizer, Moderna", "image": "https://images.financialmodelingprep.com/news/covid-vaccines-heres-what-jj-has-to-do-to-20210125.jpg", "site": "investors.com", "text": "Johnson & Johnson is expected soon to release test results for its coronavirus vaccine in a move that could rock vaccine stocks Pfizer and Moderna. Pfizer and Moderna have authorized drugs.", "url": "https://www.investors.com/news/technology/vaccine-stocks-will-johnson-johnson-coronavirus-vaccine-undercut-pfizer-moderna/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-25T16:36:51-05:00", "date_et": "2021-01-25"}
{"symbol": "JNJ", "publishedDate": "2021-01-25 17:21:16", "publisher": "InvestorPlace", "title": "4 Top Stock Trades for Tuesday: GME, CLX, JNJ, MCD", "image": "https://images.financialmodelingprep.com/news/4-top-stock-trades-for-tuesday-gme-clx-jnj-20210125.jpg", "site": "investorplace.com", "text": "GameStop, Clorox, Johnson & Johnson and McDonald's were our top stock trades for Tuesday. Now, let's look at the charts after a busy day.", "url": "https://investorplace.com/2021/01/4-top-stock-trades-for-tuesday-gme-clx-jnj-mcd/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-25T17:21:16-05:00", "date_et": "2021-01-25"}
{"symbol": "JNJ", "publishedDate": "2021-01-25 17:24:00", "publisher": "Market Watch", "title": "J&J Snack stock drops 14% as earnings miss Street expectations", "image": "https://images.financialmodelingprep.com/news/jj-snack-stock-drops-14-as-earnings-miss-street-20210125.jpg", "site": "marketwatch.com", "text": "J&J Snack Foods Corp. JJSF shares dropped after the snack food company's quarterly earnings fell short of Wall Street estimates. J&J Snack shares fell 14% after hours, following a 2.5% rise to close the session at $156.89.", "url": "https://www.marketwatch.com/story/j-j-snack-stock-drops-14-as-earnings-miss-street-expectations-11611613452", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-25T17:24:00-05:00", "date_et": "2021-01-25"}
{"symbol": "JNJ", "publishedDate": "2021-01-25 18:03:08", "publisher": "Zacks Investment Research", "title": "J&J Snack Foods (JJSF) Lags Q1 Earnings Estimates", "image": "https://images.financialmodelingprep.com/news/jj-snack-foods-jjsf-lags-q1-earnings-estimates-20210125.jpg", "site": "zacks.com", "text": "J&J Snack Foods (JJSF) delivered earnings and revenue surprises of -35.71% and 7.21%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/1251647/jj-snack-foods-jjsf-lags-q1-earnings-estimates", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-25T18:03:08-05:00", "date_et": "2021-01-25"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 05:30:00", "publisher": "Forbes", "title": "Johnson & Johnson's Vaccine Updates: When Will The Shot Be Available For Use?", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-vaccine-updates-when-will-the-shot-be-available-20210126.jpg", "site": "forbes.com", "text": "Johnson & Johnson's Covid-19 vaccine is one of the most closely watched shots against the novel coronavirus, given that it is backed by one of the world's largest pharma companies and is expected to require only a single dose. Here's a quick rundown of the expected timeline for the vaccine's.", "url": "https://www.forbes.com/sites/greatspeculations/2021/01/26/johnson--johnsons-vaccine-updates-when-will-the-shot-be-available-for-use/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T05:30:00-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 06:09:00", "publisher": "The Motley Fool", "title": "Should You Buy Johnson & Johnson Stock Before Its Big Coronavirus Vaccine News?", "image": "https://images.financialmodelingprep.com/news/should-you-buy-johnson-johnson-stock-before-its-big-20210126.jpg", "site": "fool.com", "text": "The clock is definitely ticking.", "url": "https://www.fool.com/investing/2021/01/26/should-you-buy-johnson-johnson-stock-before-its-bi/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T06:09:00-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 06:30:01", "publisher": "CNBC", "title": "J&J beats fourth-quarter earnings expectations, will release Covid vaccine data 'soon'", "image": "https://images.financialmodelingprep.com/news/jj-beats-fourthquarter-earnings-expectations-will-release-covid-vaccine-20210126.jpeg", "site": "cnbc.com", "text": "The drug and and consumer products company reported adjusted earnings of $1.86 per share, higher than the $1.82 expected in a survey of analysts by Refinitiv.", "url": "https://www.cnbc.com/2021/01/26/johnson-johnson-jnj-earnings-q4-2020.html", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T06:30:01-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 06:41:00", "publisher": "Reuters", "title": "Johnson & Johnson quarterly sales rise 8.3%, sees vaccine data \"soon\"", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-quarterly-sales-rise-83-sees-vaccine-data-20210126.jpg", "site": "reuters.com", "text": "Johnson & Johnson on Tuesday posted an 8.3% rise in quarterly sales and said it would share details from its keenly watched coronavirus vaccine trial soon, as the healthcare conglomerate races to develop a potential single-dose vaccine for COVID-19.", "url": "https://www.reuters.com/article/us-johnson-johnson-results/johnson-johnson-quarterly-sales-rise-8-3-sees-vaccine-data-soon-idUSKBN29V197", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T06:41:00-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 06:42:00", "publisher": "PRNewsWire", "title": "Johnson & Johnson Reports 2020 Fourth-Quarter And Full Year Results", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reports-2020-fourthquarter-and-full-year-results-20210126.jpg", "site": "prnewswire.com", "text": "NEW BRUNSWICK, N.J., Jan. 26, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2020. \"Our notable full year performance reflects the continued confidence from patients, physicians, customers and consumers in our life-enhancing...", "url": "https://www.prnewswire.com/news-releases/johnson--johnson-reports-2020-fourth-quarter-and-full-year-results-301214853.html", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T06:42:00-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 07:31:19", "publisher": "Market Watch", "title": "J&J beats earnings estimates in Q4, driven by a 16% jump in sales of Remicade", "image": "https://images.financialmodelingprep.com/news/jj-beats-earnings-estimates-in-q4-driven-by-a-20210126.jpg", "site": "marketwatch.com", "text": "Shares of Johnson & Johnson were up 0.5% in premarket trading on Tuesday after the company had higher-than-expected sales in the fourth quarter, despite the ongoing impact of the COVID-19 pandemic on companies that sell medical products. J&J had earnings of $1.7 billion, or 65 cents per share, in the fourth of quarter of 2020, compared with $4.0 billion, or $1.50 per share, in the same quarter a year ago.", "url": "https://www.marketwatch.com/story/jj-beats-earnings-estimates-in-q4-driven-by-a-16-jump-in-sales-of-remicade-2021-01-26", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T07:31:19-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 08:33:09", "publisher": "Invezz", "title": "Johnson & Johnson's sales jump to £16.35 billion in fiscal Q4", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-sales-jump-to-1635-billion-in-fiscal-20210126.jpg", "site": "invezz.com", "text": "Johnson & Johnson (NYSE: JNJ) reported its financial results for the fiscal fourth quarter on Tuesday that topped Wall Street estimates despite the impact of the ongoing Coronavirus pandemic. J&J topped analysts' forecasts in the prior quarter (Q3) as well.", "url": "https://invezz.com/news/2021/01/26/johnsons-johnsons-sales-jump-to-16-35-billion-in-fiscal-q4/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T08:33:09-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 09:02:10", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) Tops Q4 Earnings and Revenue Estimates", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-tops-q4-earnings-and-revenue-estimates-20210126.jpg", "site": "zacks.com", "text": "Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 2.76% and 3.97%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/1251790/johnson-johnson-jnj-tops-q4-earnings-and-revenue-estimates", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T09:02:10-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 09:27:49", "publisher": "Investor's Business Daily", "title": "J&J Pops On Quarterly Beat, Will 'Soon' Release Covid Vaccine Test Results", "image": "https://images.financialmodelingprep.com/news/jj-pops-on-quarterly-beat-will-soon-release-covid-20210126.jpg", "site": "investors.com", "text": "Johnson & Johnson beat fourth-quarter estimates and said it would \"soon\" release pivotal test results for its coronavirus vaccine — leading JNJ stock to pop Tuesday. The post J&J Pops On Quarterly Beat, Will 'Soon' Release Covid Vaccine Test Results appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/jnj-stock-johnson-johnson-earnings-q4-2020/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T09:27:49-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 09:31:41", "publisher": "Schaeffers Research", "title": "Sunny Outlook, Incoming Vaccine Data Lifts JNJ to Fresh Highs", "image": "https://images.financialmodelingprep.com/news/sunny-outlook-incoming-vaccine-data-lifts-jnj-to-fresh-20210126.jpg", "site": "schaeffersresearch.com", "text": "Johnson & Johnson (NYSE:JNJ) stock is getting a boost this morning, last seen up 1.8% at an all-time high of $169, after the major company posted better-than-expected fiscal fourth quarter earnings, though profits dropped 56.7% due to litigation expenses.", "url": "https://www.schaeffersresearch.com/content/news/2021/01/26/sunny-outlook-incoming-vaccine-data-lifts-jnj-to-fresh-highs", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T09:31:41-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 09:59:40", "publisher": "Fox Business", "title": "J&J Covid-19 vaccine data due 'soon' as drug maker boosts outlook", "image": "https://images.financialmodelingprep.com/news/jj-covid19-vaccine-data-due-soon-as-drug-maker-boosts-20210126.jpg", "site": "foxbusiness.com", "text": "The world's biggest maker of health care products topped profit and sales expectations.", "url": "https://www.foxbusiness.com/markets/jj-covid-19-vaccine-data-due-soon-after-boosting-outlook", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T09:59:40-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 11:15:47", "publisher": "Investopedia", "title": "Johnson & Johnson (JNJ) Surges to All-Time High", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-surges-to-alltime-high-20210126.jpg", "site": "investopedia.com", "text": "Johnson & Johnson (JNJ) stock has rallied to an all-time high in reaction to a strong quarter and next week's vaccine data release.", "url": "https://www.investopedia.com/johnson-and-johnson-jnj-surges-to-all-time-high-5097426", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T11:15:47-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 11:17:12", "publisher": "Zacks Investment Research", "title": "Housing Charges Economy: +9.5% Case Shiller & DHI's Earnings Beat", "image": "https://images.financialmodelingprep.com/news/housing-charges-economy-95-case-shiller-dhis-earnings-beat-20210126.jpg", "site": "zacks.com", "text": "Record-low interest rates, along with Americans moving away from the big cities, helped lead the housing formation run.", "url": "https://www.zacks.com/stock/news/1251894/housing-charges-economy-%2B95-case-shiller-dhis-earnings-beat", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T11:17:12-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 11:17:28", "publisher": "Zacks Investment Research", "title": "J&J (JNJ) Q4 Earnings & Sales Beat, 2021 Guidance Upbeat", "image": "https://images.financialmodelingprep.com/news/jj-jnj-q4-earnings-sales-beat-2021-guidance-upbeat-20210126.jpeg", "site": "zacks.com", "text": "J&J (JNJ) beats fourth-quarter 2020 estimates for both earnings and sales. It issues its adjusted earnings and sales outlook for 2021.", "url": "https://www.zacks.com/stock/news/1251881/jj-jnj-q4-earnings-sales-beat-2021-guidance-upbeat", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T11:17:28-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 11:23:16", "publisher": "GuruFocus", "title": "Johnson & Johnson Shares Pop on Stronger-Than-Expected 4th-Quarter Results", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-shares-pop-on-strongerthanexpected-4thquarter-results-20210126.jpg", "site": "gurufocus.com", "text": "Johnson & Johnson (NYSE:JNJ) released its fourth-quarter fiscal 2020 results before the opening bell on Jan. 26. The world's biggest maker of consumer health care products posted an earnings and revenue beat and provided a strong outlook for the full-year 2021.", "url": "https://www.gurufocus.com/news/1340903/johnson--johnson-shares-pop-on-strongerthanexpected-4thquarter-results", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T11:23:16-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 11:30:00", "publisher": "The Motley Fool", "title": "Here's Why Investors Cheered Johnson & Johnson's Q4 Results", "image": "https://images.financialmodelingprep.com/news/heres-why-investors-cheered-johnson-johnsons-q4-results-20210126.jpg", "site": "fool.com", "text": "The healthcare giant beat Wall Street expectations in Q4 and gave encouraging guidance for 2021.", "url": "https://www.fool.com/investing/2021/01/26/heres-why-investors-cheered-johnson-johnsons-q4-re/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T11:30:00-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 11:39:37", "publisher": "Business Insider", "title": "Johnson & Johnson's CEO says crucial coronavirus vaccine data will come by early next week", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-ceo-says-crucial-coronavirus-vaccine-data-will-20210126.jpg", "site": "businessinsider.com", "text": "The world is days away from getting crucial results on one of the most important coronavirus vaccines in development. Johnson & Johnson CEO Alex Gorsky said Tuesday the healthcare giant will have results from a 45,000-person study testing its single-dose COVID-19 vaccine by early next week.", "url": "https://www.businessinsider.com/jj-single-dose-coronavirus-vaccine-data-to-come-within-days-2021-1", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T11:39:37-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 12:02:23", "publisher": "Zacks Investment Research", "title": "Home Prices Rose in November", "image": "https://images.financialmodelingprep.com/news/home-prices-rose-in-november-20210126.jpg", "site": "zacks.com", "text": "Home Prices Rose in November", "url": "https://www.zacks.com/stock/news/1251901/home-prices-rose-in-november", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T12:02:23-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 12:39:05", "publisher": "Market Watch", "title": "J&J CEO: Expect Phase 3 results for its COVID-19 vaccine candidate early next week", "image": "https://images.financialmodelingprep.com/news/jj-ceo-expect-phase-3-results-for-its-covid19-20210126.jpg", "site": "marketwatch.com", "text": "Johnson & Johnson expects to share details from the Phase 3 clinical trial for its COVID-19 vaccine candidate \"early next week,\" according to remarks made by CEO Alex Gorsky on Tuesday during an earnings call. J&J's stock was up 3.0% in trading on Tuesday afternoon.", "url": "https://www.marketwatch.com/story/jj-ceo-expect-phase-3-results-for-its-covid-19-vaccine-candidate-early-next-week-2021-01-26", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T12:39:05-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 14:02:20", "publisher": "Seeking Alpha", "title": "Johnson & Johnson (JNJ) CEO Alex Gorsky on Q4 2020 Results - Earnings Call Transcript", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-ceo-alex-gorsky-on-q4-2020-results-20210126.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson (JNJ) CEO Alex Gorsky on Q4 2020 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4401077-johnson-johnson-jnj-ceo-alex-gorsky-on-q4-2020-results-earnings-call-transcript", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T14:02:20-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 14:37:23", "publisher": "PYMNTS", "title": "Johnson & Johnson Sales Rise 8.3 Pct Amid Consumer Health, Pharmaceutical Growth", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-sales-rise-83-pct-amid-consumer-health-20210126.jpg", "site": "pymnts.com", "text": "Johnson & Johnson reported on Tuesday (Jan. 26) as part of its financial results that reported sales grew by 8.3 percent from Q4 2019 to Q4 2020, as consumer health and pharmaceutical sales rose while medical devices worldwide operational sales fell amid the pandemic. The company reported that consumer health worldwide operational sales grew 3.1 […]", "url": "https://www.pymnts.com/earnings/2021/johnson-johnson-sales-rise-8-3-pct-amid-consumer-health-pharmaceutical-growth/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T14:37:23-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 14:40:31", "publisher": "GuruFocus", "title": "Johnson & Johnson Rises on 4th-Quarter Earnings Beat", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-rises-on-4thquarter-earnings-beat-20210126.jpg", "site": "gurufocus.com", "text": "Shares of Johnson & Johnson (NYSE:JNJ), a major drug manufacturer, climbed approximately 3% on Tuesday on the back of reporting fourth-quarter earnings results that topped analyst estimates.", "url": "https://www.gurufocus.com/news/1341335/johnson--johnson-rises-on-4thquarter-earnings-beat", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T14:40:31-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-26 21:10:00", "publisher": "The Motley Fool", "title": "Johnson & Johnson Rises on Q4 Beats, Coronavirus Vaccine Hopes", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-rises-on-q4-beats-coronavirus-vaccine-hopes-20210126.jpg", "site": "fool.com", "text": "The company promises that news about its vaccine is coming soon.", "url": "https://www.fool.com/investing/2021/01/26/johnson-johnson-rises-on-q4-beats-coronavirus-vacc/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-26T21:10:00-05:00", "date_et": "2021-01-26"}
{"symbol": "JNJ", "publishedDate": "2021-01-27 08:51:18", "publisher": "Business Insider", "title": "J&J vaccine data is imminent", "image": "https://images.financialmodelingprep.com/news/jj-vaccine-data-is-imminent-20210127.jpg", "site": "businessinsider.com", "text": "Hello, Walgreens is officially getting a new leader — Starbucks COO Roz Brewer has been named the retail pharmacy's next CEO. That'll make her the only Black woman leading a Fortune 500 company.", "url": "https://www.businessinsider.com/business-insiders-biggest-healthcare-stories-for-january-27-2021-1", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-27T08:51:18-05:00", "date_et": "2021-01-27"}
{"symbol": "JNJ", "publishedDate": "2021-01-27 12:28:17", "publisher": "Seeking Alpha", "title": "Breaking Up With Johnson & Johnson: It's Not You, It's Me", "image": "https://images.financialmodelingprep.com/news/breaking-up-with-johnson-johnson-its-not-you-its-20210127.jpg", "site": "seekingalpha.com", "text": "I believe Johnson & Johnson is overvalued, and offer a demonstration. I also believe that it is overvalued enough to warrant selling part of the position.", "url": "https://seekingalpha.com/article/4401314-breaking-up-johnson-johnson-not-you-me", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-27T12:28:17-05:00", "date_et": "2021-01-27"}
{"symbol": "JNJ", "publishedDate": "2021-01-27 12:47:23", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-is-a-top-dividend-stock-right-20210127.jpg", "site": "zacks.com", "text": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?", "url": "https://www.zacks.com/stock/news/1252643/johnson-johnson-jnj-is-a-top-dividend-stock-right-now-should-you-buy", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-27T12:47:23-05:00", "date_et": "2021-01-27"}
{"symbol": "JNJ", "publishedDate": "2021-01-27 13:32:08", "publisher": "Zacks Investment Research", "title": "JNJ Touches New Highs Post Solid Q4 Earnings: ETFs in Focus", "image": "https://images.financialmodelingprep.com/news/jnj-touches-new-highs-post-solid-q4-earnings-etfs-20210127.jpg", "site": "zacks.com", "text": "The solid results coupled with upbeat vaccine data optimism pushed JNJ shares to all-time high.", "url": "https://www.zacks.com/stock/news/1252728/jnj-touches-new-highs-post-solid-q4-earnings-etfs-in-focus", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-27T13:32:08-05:00", "date_et": "2021-01-27"}
{"symbol": "JNJ", "publishedDate": "2021-01-28 01:31:03", "publisher": "Zacks Investment Research", "title": "A Positive and Reassuring Earnings Picture", "image": "https://images.financialmodelingprep.com/news/a-positive-and-reassuring-earnings-picture-20210128.jpg", "site": "zacks.com", "text": "A Positive and Reassuring Earnings Picture", "url": "https://www.zacks.com/commentary/1252808/a-positive-and-reassuring-earnings-picture", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-28T01:31:03-05:00", "date_et": "2021-01-28"}
{"symbol": "JNJ", "publishedDate": "2021-01-28 07:48:00", "publisher": "The Motley Fool", "title": "3 Great Stocks for Low-Risk Investors", "image": "https://images.financialmodelingprep.com/news/3-great-stocks-for-lowrisk-investors-20210128.jpg", "site": "fool.com", "text": "You can count on steady growth in revenue and profit with these companies.", "url": "https://www.fool.com/investing/2021/01/28/3-great-stocks-for-low-risk-investors/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-28T07:48:00-05:00", "date_et": "2021-01-28"}
{"symbol": "JNJ", "publishedDate": "2021-01-28 11:30:00", "publisher": "The Motley Fool", "title": "If You're Retired, Consider Buying These 2 Stocks", "image": "https://images.financialmodelingprep.com/news/if-youre-retired-consider-buying-these-2-stocks-20210128.jpg", "site": "fool.com", "text": "These stocks allow you to focus on your retirement activities without worrying your investments will sour.", "url": "https://www.fool.com/investing/2021/01/28/if-youre-retired-consider-buying-these-2-stocks/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-28T11:30:00-05:00", "date_et": "2021-01-28"}
{"symbol": "JNJ", "publishedDate": "2021-01-28 12:02:36", "publisher": "Zacks Investment Research", "title": "5 Big Pharma/Biotech Stocks Set to Trump Q4 Earnings Estimates", "image": "https://images.financialmodelingprep.com/news/5-big-pharmabiotech-stocks-set-to-trump-q4-earnings-20210128.jpg", "site": "zacks.com", "text": "Let us take a look at some drug/biotech stocks including Sanofi (SNY) and Merck (MRK) that are poised to beat fourth-quarter earnings estimates.", "url": "https://www.zacks.com/stock/news/1253404/5-big-pharma-biotech-stocks-set-to-trump-q4-earnings-estimates", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-28T12:02:36-05:00", "date_et": "2021-01-28"}
{"symbol": "JNJ", "publishedDate": "2021-01-28 12:42:00", "publisher": "The Motley Fool", "title": "This Company May Be the Next to Cross the Coronavirus Vaccine Finish Line", "image": "https://images.financialmodelingprep.com/news/this-company-may-be-the-next-to-cross-the-20210128.jpg", "site": "fool.com", "text": "Stay tuned for phase 3 results in the coming days.", "url": "https://www.fool.com/investing/2021/01/28/this-company-may-be-the-next-to-cross-the-coronavi/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-28T12:42:00-05:00", "date_et": "2021-01-28"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 05:11:00", "publisher": "Benzinga", "title": "Johnson & Johnson To Start With 2 Million Doses COVID-19 Vaccine Supply", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-start-with-2-million-doses-covid19-20210129.jpg", "site": "benzinga.com", "text": "Johnson & Johnson will start COVID-19 vaccine supply with 2 million doses on receiving an emergency use authorization in the U.S., according to Government Accountability Office (GAO) report.", "url": "https://www.benzinga.com/general/biotech/21/01/19388031/johnson-johnson-to-start-with-2-million-doses-covid-19-vaccine-supply", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T05:11:00-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 06:02:00", "publisher": "The Motley Fool", "title": "New to the Stock Market? 3 Investments You Can't Go Wrong With", "image": "https://images.financialmodelingprep.com/news/new-to-the-stock-market-3-investments-you-cant-20210129.jpg", "site": "fool.com", "text": "These investments are perfect for beginners.", "url": "https://www.fool.com/investing/2021/01/29/new-to-the-stock-market-3-investments-you-cant-go/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T06:02:00-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 07:23:00", "publisher": "The Motley Fool", "title": "Better Coronavirus Stock: Johnson & Johnson vs. Pfizer", "image": "https://images.financialmodelingprep.com/news/better-coronavirus-stock-johnson-johnson-vs-pfizer-20210129.jpg", "site": "fool.com", "text": "Pfizer already is putting its COVID-19 vaccine into people's arms, while Johnson & Johnson's is waiting to be approved.", "url": "https://www.fool.com/investing/2021/01/29/better-coronavirus-stock-johnson-johnson-vs-pfizer/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T07:23:00-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 08:00:00", "publisher": "PRNewsWire", "title": "Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-announces-singleshot-janssen-covid19-vaccine-candidate-met-20210129.jpg", "site": "prnewswire.com", "text": "NEW BRUNSWICK, N.J., Jan. 29, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen...", "url": "https://www.prnewswire.com/news-releases/johnson--johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial-301218035.html", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T08:00:00-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 08:00:07", "publisher": "CNBC", "title": "J&J says its one-shot Covid vaccine is 72% effective in the U.S., but less potent in other regions", "image": "https://images.financialmodelingprep.com/news/jj-says-its-oneshot-covid-vaccine-is-72-effective-20210129.jpeg", "site": "cnbc.com", "text": "The Covid vaccine was well tolerated, with no significant safety concerns related to the vaccine reported, J&J said. There were also no reports of anaphylaxis.", "url": "https://www.cnbc.com/2021/01/29/covid-vaccine-jjs-one-shot-drug-is-72percent-in-the-us-but-less-effective-elsewhere.html", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T08:00:07-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 08:01:18", "publisher": "Business Insider", "title": "J&J's single-dose coronavirus vaccine is 66% effective against COVID-19, raising worries that some variants may lower protection", "image": "https://images.financialmodelingprep.com/news/jjs-singledose-coronavirus-vaccine-is-66-effective-against-covid19-20210129.jpg", "site": "businessinsider.com", "text": "The US effort to halt the coronavirus got some good news on Friday as another vaccine succeeded in the final stages of clinical research. The single-dose vaccine, developed by healthcare giant Johnson & Johnson with US government funding, proved to be 66% effective at preventing people from catching COVID-19, J&J said in a statement. That's significantly lower than the protection offered by shots from Pfizer and from Moderna, though both of those shots require two doses.", "url": "https://www.businessinsider.com/jj-one-dose-covid-vaccine-late-stage-trial-results-2021-1", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T08:01:18-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 08:13:33", "publisher": "Market Watch", "title": "Johnson & Johnson says COVID vaccine was 66% effective in Phase 3 trial", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-says-covid-vaccine-was-66-effective-in-20210129.jpg", "site": "marketwatch.com", "text": "Johnson & Johnson said Friday a Phase 3 trial of its one-dose COVID-19 vaccine proved to be 66% effective overall in preventing moderate-to-severe disease 28 days after vaccination, raising hopes it may receive emergency use authorization in the U.S. in the coming weeks. The vaccine candidate was 72% effective in the U.S. trial, the company said in a statement.", "url": "https://www.marketwatch.com/story/johnson-johnson-says-covid-vaccine-was-66-effective-in-phase-3-trial-2021-01-29", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T08:13:33-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 08:38:43", "publisher": "Forbes", "title": "Johnson & Johnson's Single-Dose Covid-19 Vaccine Is 66% Effective In Global Trial, But Has Lower Efficacy Against South African Variant", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-singledose-covid19-vaccine-is-66-effective-in-20210129.jpg", "site": "forbes.com", "text": "In the U.S. the vaccine had an effectiveness of 72% but that number dropped to just 57% in South Africa where a more infectious variant of the virus is spreading.", "url": "https://www.forbes.com/sites/siladityaray/2021/01/29/johnson--johnsons-single-dose-covid-19-vaccine-is-66-effective-in-global-trial-but-has-lower-efficacy-against-south-african-variant/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T08:38:43-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 08:59:00", "publisher": "Barron's", "title": "JNJ Drops, GameStop Keeps Flying as Vaccine News Hits the Dow", "image": "https://images.financialmodelingprep.com/news/jnj-drops-gamestop-keeps-flying-as-vaccine-news-hits-20210129.jpg", "site": "barrons.com", "text": "Futures on the Dow Jones Industrial Average and other major stock indexes are falling in response to the latest vaccine-trial data.", "url": "https://www.barrons.com/articles/stocks-moving-premarket-friday-jnj-gamestop-amc-novavax-51611928781", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T08:59:00-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 09:04:52", "publisher": "TechCrunch", "title": "Johnson & Johnson's COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-covid19-vaccine-is-85-effective-against-severe-20210129.jpg", "site": "techcrunch.com", "text": "Another COVID-19 vaccine is almost ready to begin being distributed – a single-shot inoculation made by Johnson & Johnson's Janssen pharmaceutical subsidiary. The company just released an efficacy report based on data from its Phase 3 trial, which found that the new vaccine is 66% effective overall in preventing moderate to severe incarnations of COVID-19 […]", "url": "https://techcrunch.com/2021/01/29/johnson-johnsons-covid-19-vaccine-is-85-effective-against-severe-cases-and-66-effective-overall-per-trial-data/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T09:04:52-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 09:29:00", "publisher": "Barron's", "title": "Johnson & Johnson Single-Dose Vaccine Found Effective Against Severe Covid-19 Infections", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-singledose-vaccine-found-effective-against-severe-covid19-20210129.jpg", "site": "barrons.com", "text": "Here's what you need to know about the impact of Covid-19 to navigate the markets today.", "url": "https://www.barrons.com/articles/news-updates-51611930488", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T09:29:00-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 09:37:00", "publisher": "Reuters", "title": "Wall St. opens lower after J&J vaccine data", "image": "https://images.financialmodelingprep.com/news/wall-st-opens-lower-after-jj-vaccine-data-20210129.jpg", "site": "reuters.com", "text": "Wall Street's main indexes opened lower on Friday after COVID-19 vaccine data from Johnson & Johnson hurt sentiment and added to worries over a growing standoff between hedge funds and retail investors.", "url": "https://www.reuters.com/article/us-usa-stocks/wall-st-opens-lower-after-jj-vaccine-data-idUSKBN29Y1MV", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T09:37:00-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 09:45:44", "publisher": "Forbes", "title": "Speculative Trading Heightens Uncertainty; JNJ Reports Vaccine 66% Effective Globally", "image": "https://images.financialmodelingprep.com/news/speculative-trading-heightens-uncertainty-jnj-reports-vaccine-66-effective-globally-20210129.jpg", "site": "forbes.com", "text": "This morning, the stock market continues to fret about certain highly speculative trades; JNJ reports vaccine is 66% effective globally", "url": "https://www.forbes.com/sites/jjkinahan/2021/01/29/speculative-trading-heightens-uncertainty-jnj-reports-vaccine-66-effective-globally/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T09:45:44-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 10:10:38", "publisher": "Investopedia", "title": "Moderna (MRNA) at High as Johnson & Johnson (JNJ) Vaccine Disappoints", "image": "https://images.financialmodelingprep.com/news/moderna-mrna-at-high-as-johnson-johnson-jnj-vaccine-20210129.jpg", "site": "investopedia.com", "text": "Inferior effectiveness of the Johnson & Johnson vaccine is unlikely to instill public confidence.", "url": "https://www.investopedia.com/moderna-mrna-at-high-as-johnson-and-johnson-jnj-vaccine-disappoints-5100992", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T10:10:38-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 10:33:32", "publisher": "Benzinga", "title": "Johnson & Johnson's COVID-19 Vaccine Data: What You Need to Know", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-covid19-vaccine-data-what-you-need-to-20210129.jpg", "site": "benzinga.com", "text": "Johnson & Johnson (NYSE: JNJ) released much-awaited top-line results Friday from a large scale, late-stage study of its coronavirus vaccine candidate. The data hasn't gone down well with investors, with the shares of the health care company ticking lower in the session.", "url": "https://www.benzinga.com/general/biotech/21/01/19393568/johnson-johnsons-covid-19-vaccine-data-what-you-need-to-know", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T10:33:32-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 10:56:00", "publisher": "Schaeffers Research", "title": "Blue-Chip Pharma Stock Dips on Vaccine Update", "image": "https://images.financialmodelingprep.com/news/bluechip-pharma-stock-dips-on-vaccine-update-20210129.jpg", "site": "schaeffersresearch.com", "text": "The shares of Johnson & Johnson (NYSE:JNJ) are down 3.4% at $163.22 at last check, after releasing new coronavirus vaccine data.", "url": "https://www.schaeffersresearch.com/content/news/2021/01/29/blue-chip-pharma-stock-dips-on-vaccine-update", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T10:56:00-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 11:00:00", "publisher": "Market Watch", "title": "Coronavirus Update: Vaccine hopes boosted by data from Novavax and J&J, but fears over new variants remain", "image": "https://images.financialmodelingprep.com/news/coronavirus-update-vaccine-hopes-boosted-by-data-from-novavax-20210129.jpg", "site": "marketwatch.com", "text": "The global case tally for the coronavirus-borne illness COVID-19 was headed toward 102 million on Friday, as health experts were digesting the latest vaccine updates from Novavax Inc. and Johnson & Johnson amid hopes they will soon win emergency authorization and bolster supplies.", "url": "https://www.marketwatch.com/story/vaccine-hopes-boosted-by-data-from-novavax-and-j-j-but-fears-over-new-variants-remain-11611936022", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T11:00:00-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 11:17:08", "publisher": "Zacks Investment Research", "title": "Personal Income Increased in December", "image": "https://images.financialmodelingprep.com/news/personal-income-increased-in-december-20210129.jpg", "site": "zacks.com", "text": "Personal Income Increased in December", "url": "https://www.zacks.com/stock/news/1254275/personal-income-increased-in-december", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T11:17:08-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 11:17:16", "publisher": "Zacks Investment Research", "title": "Economic Prints, Q4 Reports Up for Lilly, CAT; J&J Posts Phase-3 Data", "image": "https://images.financialmodelingprep.com/news/economic-prints-q4-reports-up-for-lilly-cat-jj-20210129.jpg", "site": "zacks.com", "text": "With the GameStop (GME) short-squeeze saga continuing, market indexes work to regain their equilibrium.", "url": "https://www.zacks.com/stock/news/1254261/economic-prints-q4-reports-up-for-lilly-cat-jj-posts-phase-3-data", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T11:17:16-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 12:49:39", "publisher": "Fast Company", "title": "What makes Johnson & Johnson's COVID-19 vaccine different? We break it down", "image": "https://images.financialmodelingprep.com/news/what-makes-johnson-johnsons-covid19-vaccine-different-we-break-20210129.jpg", "site": "fastcompany.com", "text": "Johnson & Johnson has released data from its global Phase 3 clinical trial today. Many COVID-19 vaccines have name brands attached them, but one of them has drawn a lot of attention lately.", "url": "https://www.fastcompany.com/90599466/what-makes-johnson-johnsons-covid-19-vaccine-different-we-break-it-down", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T12:49:39-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 12:56:05", "publisher": "Forbes", "title": "Top Stocks To Buy Today As Johnson & Johnson Vaccine Underwhelms Markets", "image": "https://images.financialmodelingprep.com/news/top-stocks-to-buy-today-as-johnson-johnson-vaccine-20210129.jpg", "site": "forbes.com", "text": "It's been a volatile trading week, with “Reddit investors” upending institutional investors and hedge funds by influencing a stock market rally for underperforming stocks.", "url": "https://www.forbes.com/sites/qai/2021/01/29/top-stocks-to-buy-today-as-johnson--johnson-vaccine-underwhelms-markets/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T12:56:05-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 13:08:40", "publisher": "Forbes", "title": "Top Stocks To Short Today Amid Reddit Mania And Disappointing Johnson & Johnson Data", "image": "https://images.financialmodelingprep.com/news/top-stocks-to-short-today-amid-reddit-mania-and-20210129.jpg", "site": "forbes.com", "text": "As the war between retail investors and Wall Street continues, stocks are on pace for their worst weekly declines in nearly three months.", "url": "https://www.forbes.com/sites/qai/2021/01/29/top-stocks-to-short-today-amid-reddit-mania-and-disappointing-johnson--johnson-data/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T13:08:40-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 14:01:40", "publisher": "ETF Trends", "title": "Stock ETFs Fall on Johnson & Johnson Vaccine News", "image": "https://images.financialmodelingprep.com/news/stock-etfs-fall-on-johnson-johnson-vaccine-news-20210129.jpg", "site": "etftrends.com", "text": "After a respite on Thursday, stocks and index ETFs tumbled once again on Friday after a trial result from Johnson & Johnson's coronavirus vaccine disappointed some investors. Fears about a retail trading battle between smaller and larger investing players continued.", "url": "https://www.etftrends.com/stock-etfs-fall-johnson-johnson-vaccine-news/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T14:01:40-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 14:01:49", "publisher": "Business Insider", "title": "How does Johnson & Johnson's COVID-19 vaccine stack up against shots from Pfizer and Moderna?", "image": "https://images.financialmodelingprep.com/news/how-does-johnson-johnsons-covid19-vaccine-stack-up-against-20210129.jpg", "site": "businessinsider.com", "text": "An experimental coronavirus vaccine from Johnson & Johnson is 66% effective at preventing moderate to severe COVID-19, according to new trial data the company released on Friday.  At first glance, the vaccine doesn't appear to be as stellar as authorized vaccines from Pfizer and Moderna, but it does have a few perks.", "url": "https://www.businessinsider.com/coronavirus-vaccines-compared-pfizer-moderna-johnson-and-johnson-2021-1", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T14:01:49-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 15:50:38", "publisher": "ETF Trends", "title": "U.S. Stock ETFs Slide on J&J's Weak Vaccine, GameStop Volatility", "image": "https://images.financialmodelingprep.com/news/us-stock-etfs-slide-on-jjs-weak-vaccine-gamestop-20210129.jpg", "site": "etftrends.com", "text": "U.S. markets and stock exchange traded funds retreated Friday after Johnson & Johnson's inefficient Covid-19 vaccine dinged sentiment. The ongoing fight between institutional investors and retail traders added to fears of a bubble.", "url": "https://www.etftrends.com/equity-etf-channel/u-s-stock-etfs-slide-on-jjs-weak-vaccine-gamestop-volatility/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T15:50:38-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 19:00:00", "publisher": "The Motley Fool", "title": "Why Johnson & Johnson Fell Today Despite Excellent Coronavirus Vaccine News", "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-fell-today-despite-excellent-coronavirus-vaccine-20210129.jpg", "site": "fool.com", "text": "The company's vaccine has a lower efficacy rate than others.", "url": "https://www.fool.com/investing/2021/01/29/why-johnson-johnson-fell-today-despite-excellent-c/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T19:00:00-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 19:09:48", "publisher": "CNBC", "title": "Dr. Gottlieb says J&J Covid vaccine trial yields very good result and vaccine will aid U.S. pandemic response", "image": "https://images.financialmodelingprep.com/news/dr-gottlieb-says-jj-covid-vaccine-trial-yields-very-20210129.jpeg", "site": "cnbc.com", "text": "Former FDA chief Dr. Scott Gottlieb said Johnson & Johnson's single-dose Covid vaccine will be a \"great addition\" to the U.S. pandemic response.", "url": "https://www.cnbc.com/2021/01/29/dr-scott-gottlieb-jj-covid-vaccine-trial-yields-very-good-result.html", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T19:09:48-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-29 20:24:06", "publisher": "CNBC", "title": "There will be enough Covid vaccines for the ‘entire U.S. adult population by June,' Johnson & Johnson board member says", "image": "https://images.financialmodelingprep.com/news/there-will-be-enough-covid-vaccines-for-the-entire-20210129.jpeg", "site": "cnbc.com", "text": "Johnson & Johnson board member Dr. Mark McClellan said that there could be enough vaccinations for the entire U.S. adult population by June.", "url": "https://www.cnbc.com/2021/01/29/there-will-be-enough-covid-vaccines-for-the-entire-us-adult-population-by-june-doctor-says.html", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-29T20:24:06-05:00", "date_et": "2021-01-29"}
{"symbol": "JNJ", "publishedDate": "2021-01-30 06:55:00", "publisher": "The Motley Fool", "title": "Biden's Latest Move Just Handed the Vaccine Market to These 2 Companies", "image": "https://images.financialmodelingprep.com/news/bidens-latest-move-just-handed-the-vaccine-market-to-20210130.jpg", "site": "fool.com", "text": "They can't vaccinate the whole world against COVID-19 -- but they may vaccinate all of the U.S.", "url": "https://www.fool.com/investing/2021/01/30/bidens-latest-move-just-handed-the-vaccine-market/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-30T06:55:00-05:00", "date_et": "2021-01-30"}
{"symbol": "JNJ", "publishedDate": "2021-01-30 11:09:50", "publisher": "Business Insider", "title": "Moderna vaccine creator calls Johnson & Johnson's competing shot a 'darn good' tool to fight the pandemic", "image": "https://images.financialmodelingprep.com/news/moderna-vaccine-creator-calls-johnson-johnsons-competing-shot-a-20210130.jpg", "site": "businessinsider.com", "text": "A leading coronavirus vaccine scientist who helped develop Moderna's highly effective vaccine says Johnson & Johnson's new trial results, which tout 72% efficacy for the one-shot vaccine in the US, look \"darn good.\" \"Don't let the perfect get in the way of the good enough,\" Kizzmekia Corbett, scientific lead for coronavirus vaccines in the Viral Pathogenesis Laboratory at the National Institutes of Health, wrote on Twitter Friday.", "url": "https://www.businessinsider.com/moderna-scientist-kizzy-johnson-and-johnson-covid-shot-darn-good-2021-1", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-30T11:09:50-05:00", "date_et": "2021-01-30"}
{"symbol": "JNJ", "publishedDate": "2021-01-31 06:10:00", "publisher": "The Motley Fool", "title": "Which Is the Best COVID Vaccine Stock: Pfizer, BioNTech, Moderna, Johnson & Johnson, or Novavax?", "image": "https://images.financialmodelingprep.com/news/which-is-the-best-covid-vaccine-stock-pfizer-biontech-20210131.jpg", "site": "fool.com", "text": "Hint: It's complicated.", "url": "https://www.fool.com/investing/2021/01/31/can-johnson-johnson-beat-pfizer-and-moderna-in-the/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-31T06:10:00-05:00", "date_et": "2021-01-31"}
{"symbol": "JNJ", "publishedDate": "2021-01-31 08:44:29", "publisher": "CNBC", "title": "Top Wall Street analysts like these stocks coming out of earnings season", "image": "https://images.financialmodelingprep.com/news/top-wall-street-analysts-like-these-stocks-coming-out-20210131.jpg", "site": "cnbc.com", "text": "TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Facebook and Apple", "url": "https://www.cnbc.com/2021/01/31/top-analysts-like-these-stocks-coming-out-of-earnings-season.html", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-01-31T08:44:29-05:00", "date_et": "2021-01-31"}
{"symbol": "JNJ", "publishedDate": "2021-02-01 04:16:53", "publisher": "Seeking Alpha", "title": "Week 5 MDA Breakout Stocks - February 2021: Short-Term Picks To Give You An Edge", "image": "https://images.financialmodelingprep.com/news/week-5-mda-breakout-stocks-february-2021-shortterm-picks-20210201.jpg", "site": "seekingalpha.com", "text": "Two new breakout stocks for Week 5 of 2021 with better than 10% short-term upside potential. This past week all 4 stocks gained over 10% with NBSE and QDEL gaining over 20% before pulling back on Friday to close with average +3.77% gains this week.", "url": "https://seekingalpha.com/article/4402369-week-5-mda-breakout-stocks-february-2021-short-term-picks-to-give-you-edge", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-01T04:16:53-05:00", "date_et": "2021-02-01"}
{"symbol": "JNJ", "publishedDate": "2021-02-01 08:00:00", "publisher": "Seeking Alpha", "title": "Retirement Strategy: A Surprise Update To The Pandemic Retirement Income Portfolio", "image": "https://images.financialmodelingprep.com/news/retirement-strategy-a-surprise-update-to-the-pandemic-retirement-20210201.jpg", "site": "seekingalpha.com", "text": "Retirement Strategy: A Surprise Update To The Pandemic Retirement Income Portfolio", "url": "https://seekingalpha.com/article/4402139-retirement-strategy-surprise-update-to-pandemic-retirement-income-portfolio", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-01T08:00:00-05:00", "date_et": "2021-02-01"}
{"symbol": "JNJ", "publishedDate": "2021-02-01 11:22:04", "publisher": "Zacks Investment Research", "title": "J&J's (JNJ) Coronavirus Vaccine Shows 66% Efficacy in Phase III", "image": "https://images.financialmodelingprep.com/news/jjs-jnj-coronavirus-vaccine-shows-66-efficacy-in-phase-20210201.jpg", "site": "zacks.com", "text": "J&J's (JNJ) phase III ENSEMBLE study on its single-dose COVID-19 vaccine candidate meets all primary and key secondary endpoints.", "url": "https://www.zacks.com/stock/news/1255269/jjs-jnj-coronavirus-vaccine-shows-66-efficacy-in-phase-iii", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-01T11:22:04-05:00", "date_et": "2021-02-01"}
{"symbol": "JNJ", "publishedDate": "2021-02-01 11:40:03", "publisher": "InvestorPlace", "title": "7 Blue Chip Stocks to Help Prepare For Your Retirement", "image": "https://images.financialmodelingprep.com/news/7-blue-chip-stocks-to-help-prepare-for-your-20210201.jpg", "site": "investorplace.com", "text": "These blue chip stocks have tremendous brand equity and will allow investors to rake in healthy returns while preparing for their retirement. The post 7 Blue Chip Stocks to Help Prepare For Your Retirement appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/02/7-blue-chip-stocks-help-prepare-your-retirement/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-01T11:40:03-05:00", "date_et": "2021-02-01"}
{"symbol": "JNJ", "publishedDate": "2021-02-01 22:57:26", "publisher": "Forbes", "title": "Johnson & Johnson Vaccine's 66% Efficacy Figure Is Better Than It Looks", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-vaccines-66-efficacy-figure-is-better-than-20210201.jpg", "site": "forbes.com", "text": "Johnson & Johnson announced that its single-shot Covid-19 vaccine was 66% effective in preventing moderate and severe cases of Covid-19 in its global phase 3 trials. Efficacy varied by region, with the shot proving 72% effective in the U.S., 66% effective in Latin America, and around 57% effective.", "url": "https://www.forbes.com/sites/greatspeculations/2021/02/01/johnson--johnson-vaccines-66-efficacy-figure-is-better-than-it-looks/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-01T22:57:26-05:00", "date_et": "2021-02-01"}
{"symbol": "JNJ", "publishedDate": "2021-02-02 05:52:00", "publisher": "The Motley Fool", "title": "Is Moderna Stock a Buy or Sell After Johnson & Johnson's Vaccine News?", "image": "https://images.financialmodelingprep.com/news/is-moderna-stock-a-buy-or-sell-after-johnson-20210202.jpg", "site": "fool.com", "text": "It's complicated.", "url": "https://www.fool.com/investing/2021/02/02/is-moderna-stock-a-buy-or-sell-after-johnson-johns/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-02T05:52:00-05:00", "date_et": "2021-02-02"}
{"symbol": "JNJ", "publishedDate": "2021-02-02 08:00:00", "publisher": "PRNewsWire", "title": "Johnson & Johnson Vision Receives FDA Approval For Next Generation Monofocal Intraocular Lens - TECNIS Eyhance™ And TECNIS Eyhance™ Toric II IOLs - For The Treatment Of Cataract Patients", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-vision-receives-fda-approval-for-next-generation-20210202.jpg", "site": "prnewswire.com", "text": "SANTA ANA, Calif., Feb. 2, 2021 /PRNewswire/ -- Johnson & Johnson Vision**, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies***, today announced that the U.S. Food and Drug Administration (FDA) approved the TECNIS Eyhance™ and TECNIS Eyhance™ Toric...", "url": "https://www.prnewswire.com/news-releases/johnson--johnson-vision-receives-fda-approval-for-next-generation-monofocal-intraocular-lens---tecnis-eyhance-and-tecnis-eyhance-toric-ii-iols---for-the-treatment-of-cataract-patients-301219587.html", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-02T08:00:00-05:00", "date_et": "2021-02-02"}
{"symbol": "JNJ", "publishedDate": "2021-02-02 09:45:00", "publisher": "The Motley Fool", "title": "This One Stock Market Chart Will Make You a Smarter Investor", "image": "https://images.financialmodelingprep.com/news/this-one-stock-market-chart-will-make-you-a-20210202.jpg", "site": "fool.com", "text": "Amid the craze, return to the basics.", "url": "https://www.fool.com/investing/2021/02/02/this-one-stock-market-chart-will-make-you-a-smarte/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-02T09:45:00-05:00", "date_et": "2021-02-02"}
{"symbol": "JNJ", "publishedDate": "2021-02-02 10:09:53", "publisher": "InvestorPlace", "title": "8 Dividend Stocks With a Decade of Dividend Increases", "image": "https://images.financialmodelingprep.com/news/8-dividend-stocks-with-a-decade-of-dividend-increases-20210202.jpg", "site": "investorplace.com", "text": "Dividend stocks aren't just about current yield, but payout growth over time. These 8 stocks have done a fantastic job hiking distributions.", "url": "https://investorplace.com/2021/02/8-dividend-stocks-decade-dividend-increases/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-02T10:09:53-05:00", "date_et": "2021-02-02"}
{"symbol": "JNJ", "publishedDate": "2021-02-02 13:53:38", "publisher": "Seeking Alpha", "title": "Bolt Biotherapeutics Aims For $150 Million U.S. IPO", "image": "https://images.financialmodelingprep.com/news/bolt-biotherapeutics-aims-for-150-million-us-ipo-20210202.jpg", "site": "seekingalpha.com", "text": "Bolt Biotherapeutics has filed proposed terms for a $150 million IPO. The firm is developing antibody conjugate treatments for various cancers.", "url": "https://seekingalpha.com/article/4402758-bolt-biotherapeutics-aims-for-150-million-u-s-ipo", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-02T13:53:38-05:00", "date_et": "2021-02-02"}
{"symbol": "JNJ", "publishedDate": "2021-02-02 14:49:00", "publisher": "Barron's", "title": "Pfizer Increased Vaccine Sales Estimate After AstraZeneca and J&J Stumbles", "image": "https://images.financialmodelingprep.com/news/pfizer-increased-vaccine-sales-estimate-after-astrazeneca-and-jj-20210202.jpg", "site": "barrons.com", "text": "Pfizer CEO Albert Bourla says he has grown more confident about the outlook for the vaccine.", "url": "https://www.barrons.com/articles/pfizer-increased-vaccine-sales-estimate-after-astrazeneca-and-j-j-stumbles-51612295394", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-02T14:49:00-05:00", "date_et": "2021-02-02"}
{"symbol": "JNJ", "publishedDate": "2021-02-03 06:45:00", "publisher": "The Motley Fool", "title": "3 Stocks I Can't Wait to Buy When the Stock Market Crashes Again", "image": "https://images.financialmodelingprep.com/news/3-stocks-i-cant-wait-to-buy-when-the-20210203.jpg", "site": "fool.com", "text": "If stocks drop 50% tomorrow, do you have your shopping list ready?", "url": "https://www.fool.com/investing/2021/02/03/3-stocks-i-cant-wait-to-buy-when-the-stock-market/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-03T06:45:00-05:00", "date_et": "2021-02-03"}
{"symbol": "JNJ", "publishedDate": "2021-02-04 17:35:00", "publisher": "PRNewsWire", "title": "Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-announces-submission-of-application-to-the-us-20210204.jpg", "site": "prnewswire.com", "text": "NEW BRUNSWICK, N.J., Feb. 4, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced that Janssen Biotech, Inc., has submitted an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for its investigational...", "url": "https://www.prnewswire.com/news-releases/johnson--johnson-announces-submission-of-application-to-the-us-fda-for-emergency-use-authorization-of-its-investigational-single-shot-janssen-covid-19-vaccine-candidate-301222768.html", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-04T17:35:00-05:00", "date_et": "2021-02-04"}
{"symbol": "JNJ", "publishedDate": "2021-02-04 17:52:36", "publisher": "CNBC", "title": "Johnson & Johnson requests emergency authorization from FDA for Covid vaccine", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-requests-emergency-authorization-from-fda-for-covid-vaccine-20210204.jpeg", "site": "cnbc.com", "text": "If J&J's application is approved, it would be the third authorized for emergency use in the U.S. behind vaccines developed by Pfizer-BioNTech and Moderna.", "url": "https://www.cnbc.com/2021/02/04/covid-vaccine-jj-requests-fda-emergency-use-authorization.html", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-04T17:52:36-05:00", "date_et": "2021-02-04"}
{"symbol": "JNJ", "publishedDate": "2021-02-04 17:57:42", "publisher": "Market Watch", "title": "J&J submits application for its COVID-19 shot to the FDA", "image": "https://images.financialmodelingprep.com/news/jj-submits-application-for-its-covid19-shot-to-the-20210204.jpeg", "site": "marketwatch.com", "text": "Shares of Johnson & Johnson gained 1.2% in after-hours trading on Thursday after the company announced that it had submitted an application for an emergency use authorization to the Food and Drug Administration for its COVID-19 vaccine candidate. The experimental single-dose COVID vaccine was 72% effective at preventing symptomatic disease in the U.S. arm of the Phase 3 clinical trial, according to findings released Jan. 29.", "url": "https://www.marketwatch.com/story/jj-submits-application-for-its-covid-19-shot-to-the-fda-2021-02-04", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-04T17:57:42-05:00", "date_et": "2021-02-04"}
{"symbol": "JNJ", "publishedDate": "2021-02-04 18:14:49", "publisher": "Forbes", "title": "Johnson & Johnson Files For Covid Vaccine Emergency Use Authorization", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-files-for-covid-vaccine-emergency-use-authorization-20210204.jpg", "site": "forbes.com", "text": "A third Covid vaccine could soon be available in the United States.", "url": "https://www.forbes.com/sites/nicholasreimann/2021/02/04/johnson--johnson-files-for-covid-vaccine-emergency-use-authorization/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-04T18:14:49-05:00", "date_et": "2021-02-04"}
{"symbol": "JNJ", "publishedDate": "2021-02-04 19:04:00", "publisher": "Barron's", "title": "Johnson & Johnson Seeks Emergency Authorization for Covid Vaccine", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-seeks-emergency-authorization-for-covid-vaccine-20210204.jpg", "site": "barrons.com", "text": "Johnson & Johnson said it expects to supply 100 million doses to the U.S. in the first half of the year.", "url": "https://www.barrons.com/articles/johnson-johnson-seeks-emergency-authorization-for-covid-vaccine-the-stock-moved-higher-51612483452", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-04T19:04:00-05:00", "date_et": "2021-02-04"}
{"symbol": "JNJ", "publishedDate": "2021-02-04 22:53:21", "publisher": "Benzinga", "title": "Johnson & Johnson Seeks US Emergency Approval For Single Dose COVID-19 Vaccine", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-seeks-us-emergency-approval-for-single-dose-20210204.jpg", "site": "benzinga.com", "text": "Johnson & Johnson (NYSE: JNJ) said Wednesday that its subsidiary Janssen Biotech Inc is requesting approval from the United States Food and Drug Administration for its single-dose COVID-19 vaccine candidate. What Happened: The multinational pharma company said in a statement that it is asking for an emergency use authorization from the FDA based on the results of the vaccine's Phase 3 clinical trial.", "url": "https://www.benzinga.com/general/biotech/21/02/19504227/johnson-johnson-seeks-us-emergency-approval-for-single-dose-covid-19-vaccine", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-04T22:53:21-05:00", "date_et": "2021-02-04"}
{"symbol": "JNJ", "publishedDate": "2021-02-05 05:59:00", "publisher": "Barron's", "title": "Global Stocks Cheered by JNJ Vaccine News as Investors Wait for U.S. Payrolls Data", "image": "https://images.financialmodelingprep.com/news/global-stocks-cheered-by-jnj-vaccine-news-as-investors-20210205.jpg", "site": "barrons.com", "text": "U.S. stock futures are inching up and European equities are climbing after a record session on Wall Street. Payrolls data are in the spotlight as is Covid-19 vaccine news.", "url": "https://www.barrons.com/articles/global-stocks-cheered-by-jnj-vaccine-news-as-investors-wait-for-u-s-payrolls-data-51612522775", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-05T05:59:00-05:00", "date_et": "2021-02-05"}
{"symbol": "JNJ", "publishedDate": "2021-02-05 06:25:00", "publisher": "The Motley Fool", "title": "Is Johnson & Johnson a Great Dividend Stock?", "image": "https://images.financialmodelingprep.com/news/is-johnson-johnson-a-great-dividend-stock-20210205.jpg", "site": "fool.com", "text": "The company has been increasing its payouts for decades.", "url": "https://www.fool.com/investing/2021/02/05/is-johnson-johnson-a-great-dividend-stock/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-05T06:25:00-05:00", "date_et": "2021-02-05"}
{"symbol": "JNJ", "publishedDate": "2021-02-05 07:31:31", "publisher": "Market Watch", "title": "FDA schedules advisory committee for J&J's COVID-19 vaccine candidate for Feb. 26", "image": "https://images.financialmodelingprep.com/news/fda-schedules-advisory-committee-for-jjs-covid19-vaccine-candidate-20210205.jpg", "site": "marketwatch.com", "text": "A Food and Drug Administration advisory committee is now scheduled to meet Feb. 26 for an all-day meeting to discuss Johnson & Johnson's COVID-19 vaccine candidate. This is the next step in the regulatory process after J&J said Thursday it has submitted an application for its experimental vaccine to the FDA.", "url": "https://www.marketwatch.com/story/fda-schedules-advisory-committee-for-jjs-covid-19-vaccine-candidate-for-feb-26-2021-02-05", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-05T07:31:31-05:00", "date_et": "2021-02-05"}
{"symbol": "JNJ", "publishedDate": "2021-02-05 10:30:00", "publisher": "Seeking Alpha", "title": "Johnson & Johnson Stock Belongs In Every Portfolio", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-stock-belongs-in-every-portfolio-20210205.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson Stock Belongs In Every Portfolio", "url": "https://seekingalpha.com/article/4403797-johnson-johnson-stock-belongs-in-every-portfolio", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-05T10:30:00-05:00", "date_et": "2021-02-05"}
{"symbol": "JNJ", "publishedDate": "2021-02-05 11:43:50", "publisher": "Investor's Business Daily", "title": "J&J, Novavax Ask FDA To Authorize Covid Vaccines — Shares Surge Higher", "image": "https://images.financialmodelingprep.com/news/jj-novavax-ask-fda-to-authorize-covid-vaccines-shares-surge-20210205.jpg", "site": "investors.com", "text": "Johnson & Johnson and Novavax asked the Food and Drug Administration to authorize their coronavirus vaccines late Thursday — and both vaccine stocks jumped Friday. The post J&J, Novavax Ask FDA To Authorize Covid Vaccines — Shares Surge Higher appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/vaccine-stock-johnson-johnson-asks-fda-covid-vaccine-nod-branch/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-05T11:43:50-05:00", "date_et": "2021-02-05"}
{"symbol": "JNJ", "publishedDate": "2021-02-05 12:07:07", "publisher": "Zacks Investment Research", "title": "J&J (JNJ) Seeks Emergency Approval for Coronavirus Vaccine", "image": "https://images.financialmodelingprep.com/news/jj-jnj-seeks-emergency-approval-for-coronavirus-vaccine-20210205.jpg", "site": "zacks.com", "text": "Johnson & Johnson (JNJ) submits regulatory application to the FDA seeking emergency use approval for its single-shot coronavirus vaccine.", "url": "https://www.zacks.com/stock/news/1258382/jj-jnj-seeks-emergency-approval-for-coronavirus-vaccine", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-05T12:07:07-05:00", "date_et": "2021-02-05"}
{"symbol": "JNJ", "publishedDate": "2021-02-05 13:38:16", "publisher": "Zacks Investment Research", "title": "Pharma ETFs in Focus Post Q4 Earnings", "image": "https://images.financialmodelingprep.com/news/pharma-etfs-in-focus-post-q4-earnings-20210205.jpg", "site": "zacks.com", "text": "Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.", "url": "https://www.zacks.com/stock/news/1258521/pharma-etfs-in-focus-post-q4-earnings", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-05T13:38:16-05:00", "date_et": "2021-02-05"}
{"symbol": "JNJ", "publishedDate": "2021-02-05 15:00:00", "publisher": "The Motley Fool", "title": "When Will Johnson & Johnson's Coronavirus Vaccine Be Available?", "image": "https://images.financialmodelingprep.com/news/when-will-johnson-johnsons-coronavirus-vaccine-be-available-20210205.jpg", "site": "fool.com", "text": "The clinical trial data was solid enough, but it'll be a few weeks before it could be authorized.", "url": "https://www.fool.com/investing/2021/02/05/when-will-johnson-johnsons-coronavirus-vaccine-be/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-05T15:00:00-05:00", "date_et": "2021-02-05"}
{"symbol": "JNJ", "publishedDate": "2021-02-06 05:59:00", "publisher": "The Motley Fool", "title": "2 Green Flags in Johnson & Johnson's Latest Earnings Report", "image": "https://images.financialmodelingprep.com/news/2-green-flags-in-johnson-johnsons-latest-earnings-report-20210206.jpg", "site": "fool.com", "text": "Strong pharmaceutical sales and an impressive growth forecast gave investors reasons to smile.", "url": "https://www.fool.com/investing/2021/02/06/2-green-flags-in-johnson-johnsons-latest-earnings/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-06T05:59:00-05:00", "date_et": "2021-02-06"}
{"symbol": "JNJ", "publishedDate": "2021-02-06 06:32:00", "publisher": "The Motley Fool", "title": "Johnson & Johnson's Vaccine Is Less Effective Than Rivals. Here's Why It Could Still Win Big", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-vaccine-is-less-effective-than-rivals-heres-20210206.jpg", "site": "fool.com", "text": "There's good news for those organizing vaccine logistics and the people sticking out an arm.", "url": "https://www.fool.com/investing/2021/02/06/johnson-johnsons-vaccine-is-less-effective-than-ri/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-06T06:32:00-05:00", "date_et": "2021-02-06"}
{"symbol": "JNJ", "publishedDate": "2021-02-06 13:03:19", "publisher": "Seeking Alpha", "title": "Week 6 MDA Breakout Stocks - February 2021: Short-Term Picks To Give You An Edge", "image": "https://images.financialmodelingprep.com/news/week-6-mda-breakout-stocks-february-2021-shortterm-picks-20210206.jpg", "site": "seekingalpha.com", "text": "Week 6 MDA Breakout Stocks - February 2021: Short-Term Picks To Give You An Edge", "url": "https://seekingalpha.com/article/4404108-week-6-mda-breakout-stocks-february-2021-short-term-picks-to-give-you-edge", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-06T13:03:19-05:00", "date_et": "2021-02-06"}
{"symbol": "JNJ", "publishedDate": "2021-02-07 07:07:00", "publisher": "The Motley Fool", "title": "3 Stocks to Bankroll Your Retirement", "image": "https://images.financialmodelingprep.com/news/3-stocks-to-bankroll-your-retirement-20210207.jpg", "site": "fool.com", "text": "How does a 4.6% dividend yield sound?", "url": "https://www.fool.com/investing/2021/02/07/3-stocks-to-bankroll-your-retirement/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-07T07:07:00-05:00", "date_et": "2021-02-07"}
{"symbol": "JNJ", "publishedDate": "2021-02-07 08:58:00", "publisher": "The Motley Fool", "title": "1 Big Problem in Johnson & Johnson's Latest Earnings Call", "image": "https://images.financialmodelingprep.com/news/1-big-problem-in-johnson-johnsons-latest-earnings-call-20210207.jpg", "site": "fool.com", "text": "The coronavirus pandemic continues to pressure one of the company's big operating segments.", "url": "https://www.fool.com/investing/2021/02/07/1-big-problem-in-johnson-johnsons-latest-earnings/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-07T08:58:00-05:00", "date_et": "2021-02-07"}
{"symbol": "JNJ", "publishedDate": "2021-02-07 14:54:52", "publisher": "Proactive Investors", "title": "Johnson & Johnson submits one-shot coronavirus vaccine for US approval", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-submits-oneshot-coronavirus-vaccine-for-us-approval-20210207.jpg", "site": "proactiveinvestors.co.uk", "text": "Johnson & Johnson  Inc (NYSE:JNJ) said last night it has filed for emergency use authorisation of its one-dose Coronavirus (COVID-19) vaccine with US regulator, the Food & Drug Administration (FDA). The application follows the publication of trial data last month that showed the drug was 66% effective in preventing infections, though the figure was higher at 72% among US participants.", "url": "https://www.proactiveinvestors.co.uk//companies/news/940519/johnson--johnson-submits-one-shot-coronavirus-vaccine-for-us-approval-940519.html?SNAPI", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-07T14:54:52-05:00", "date_et": "2021-02-07"}
{"symbol": "JNJ", "publishedDate": "2021-02-08 10:19:00", "publisher": "The Motley Fool", "title": "Why Johnson & Johnson's Vaccine Data Is Actually Great News", "image": "https://images.financialmodelingprep.com/news/why-johnson-johnsons-vaccine-data-is-actually-great-news-20210208.jpg", "site": "fool.com", "text": "A few numbers from phase 3 trials stuck out for the wrong reasons. But looking closer, there's plenty to celebrate.", "url": "https://www.fool.com/investing/2021/02/08/why-johnson-johnsons-vaccine-data-is-actually-grea/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-08T10:19:00-05:00", "date_et": "2021-02-08"}
{"symbol": "JNJ", "publishedDate": "2021-02-08 18:57:21", "publisher": "Zacks Investment Research", "title": "New All-Time Highs for Dow, Nasdaq, S&P and Russell", "image": "https://images.financialmodelingprep.com/news/new-alltime-highs-for-dow-nasdaq-sp-and-russell-20210208.jpg", "site": "zacks.com", "text": "We're not seeing any real earth-shattering developments that might be spurring the markets near-term; we see a lot of positive sentiment pivoting of the $1.9 trillion stimulus package.", "url": "https://www.zacks.com/stock/news/1259477/new-all-time-highs-for-dow-nasdaq-sp-and-russell", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-08T18:57:21-05:00", "date_et": "2021-02-08"}
{"symbol": "JNJ", "publishedDate": "2021-02-09 05:43:11", "publisher": "Benzinga", "title": "Janssen's Erleada Plus, Zytiga Plus Prednisone Combo Treatment Shows Clinical Benefit In Late-Stage Prostate Cancer Study", "image": "https://images.financialmodelingprep.com/news/janssens-erleada-plus-zytiga-plus-prednisone-combo-treatment-shows-20210209.jpg", "site": "benzinga.com", "text": "Johnson & Johnson's (NYSE: JNJ) unit Janssen Pharmaceutical has announced results from Phase 3 ACIS study, evaluating the efficacy and safety of Erleada (apalutamide) and Zytiga (abiraterone) plus prednisone (treatment arm) compared to placebo and Zytiga plus prednisone (control arm) in prostate cancer patients with chemotherapy-naïve disease who received androgen deprivation therapy. JNJ will present the results at the American Society of Clinical Oncology's Genitourinary Cancers Symposium.", "url": "https://www.benzinga.com/general/biotech/21/02/19556352/janssens-erleada-plus-zytiga-plus-prednisone-combo-treatment-shows-clinical-benefit-in-late-stage", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-09T05:43:11-05:00", "date_et": "2021-02-09"}
{"symbol": "JNJ", "publishedDate": "2021-02-09 06:09:00", "publisher": "The Motley Fool", "title": "How Will Johnson & Johnson's COVID Vaccine Affect Its Stock?", "image": "https://images.financialmodelingprep.com/news/how-will-johnson-johnsons-covid-vaccine-affect-its-stock-20210209.jpg", "site": "fool.com", "text": "The answer is different for the long term than for the short term.", "url": "https://www.fool.com/investing/2021/02/09/how-will-johnson-johnsons-covid-vaccine-affect-its/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-09T06:09:00-05:00", "date_et": "2021-02-09"}
{"symbol": "JNJ", "publishedDate": "2021-02-09 06:11:00", "publisher": "The Motley Fool", "title": "Here's Why Investors Should Remember These 2 Healthcare Lessons in 2021", "image": "https://images.financialmodelingprep.com/news/heres-why-investors-should-remember-these-2-healthcare-lessons-20210209.jpg", "site": "fool.com", "text": "If you're thinking about investing in healthcare stocks this year, remember these two things.", "url": "https://www.fool.com/investing/2021/02/09/heres-why-investors-should-remember-these-2-health/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-09T06:11:00-05:00", "date_et": "2021-02-09"}
{"symbol": "JNJ", "publishedDate": "2021-02-09 13:27:58", "publisher": "InvestorPlace", "title": "7 Safe Stocks for Reddit's WSB Bull Gang", "image": "https://images.financialmodelingprep.com/news/7-safe-stocks-for-reddits-wsb-bull-gang-20210209.jpg", "site": "investorplace.com", "text": "The short-squeeze is putting negative selling pressure on a wide range of stocks, so investors need to carefully select the safest plays. The post 7 Safe Stocks for Reddit's WSB Bull Gang appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/02/7-safe-stocks-for-reddits-wsb-bull-gang/", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-09T13:27:58-05:00", "date_et": "2021-02-09"}
{"symbol": "JNJ", "publishedDate": "2021-02-09 14:55:29", "publisher": "CNBC", "title": "J&J CEO says people may need annual Covid vaccine shots for the next several years", "image": "https://images.financialmodelingprep.com/news/jj-ceo-says-people-may-need-annual-covid-vaccine-20210209.jpg", "site": "cnbc.com", "text": "", "url": "https://www.cnbc.com/2021/02/09/covid-vaccine-jj-ceo-says-people-may-get-annual-shots-for-the-next-several-years.html", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-09T14:55:29-05:00", "date_et": "2021-02-09"}
{"symbol": "JNJ", "publishedDate": "2021-02-09 18:47:00", "publisher": "Market Watch", "title": "Key Words: Expect to get COVID-19 shots for years to come, Johnson & Johnson CEO says", "image": "https://images.financialmodelingprep.com/news/key-words-expect-to-get-covid19-shots-for-years-20210209.jpg", "site": "marketwatch.com", "text": "In an interview with CNBC, CEO Alex Gorsky said mutations of the coronavirus will necessitate changes to vaccines, much like annual flu shots.", "url": "https://www.marketwatch.com/story/expect-to-get-covid-19-shots-for-years-to-come-johnson-johnson-ceo-says-11612914428", "ticker": "JNJ", "event_date": "2021-01-26", "window_start": "2021-01-19", "window_end": "2021-02-09", "publishedDateET": "2021-02-09T18:47:00-05:00", "date_et": "2021-02-09"}
